Diazepam is a drug with anxiolytic, hypnotic, anticonvulsant, sedative and central muscle relaxant effects. Diazepam lowers the severity of emotional stress, reduces anxiety, and also lowers increased muscle tone. The effect of the drug is based on its ability to enhance the central effect of gamma-aminobutyric acid (one of the inhibitory mediators of the central nervous system) on the receptors of the reticular formation of the brain column. Diazepam leads to a decrease in excitation of the cerebral cortex, hypothalamus, thalamus and limbic system. Diazepam has a muscle relaxant effect due to the slowing down of postsynaptic spinal reflexes.
With alcohol withdrawal, diazepam helps to reduce the severity of the acute state of agitation, tremor, acute alcoholic delirium, hallucinations and negativism.
With constant administration, the effect of the drug is enhanced due to the mellen excretion and, as a result, the accumulation of diazepam in the tissues.
The initial levels of diazepam decrease quite rapidly within 6 hours, after which the decline in plasma concentrations slows down. The half-life of diazepam ranges from 20 to 70 hours, depending on the individual characteristics of patients.
Diazepam is metabolized in the liver with the formation of active substances (the main metabolite N-desmethyldiazepam is determined in plasma 24-36 hours after drug administration).
Diazepam and its metabolites are excreted mainly by the kidneys.

Indications for use

Diazepam in the form of a parenteral solution is used to treat patients with acute neuropsychic stress, which is accompanied by insomnia, tension, anxiety and fear.
Diazepam is used to treat patients with epilepsy, severe emotional manifestations and spastic paralysis.
Diazepam may also be prescribed for alcohol withdrawal and delirium tremens.

Mode of application

Diazepam solution is intended for parenteral use. The drug is administered intravenously or intramuscularly. Intravenous Diazepam is allowed to be administered drip and jet. Intramuscularly, it is suggested to inject only into large muscles (in particular, the gluteal muscle), observing the rules for intramuscular administration of solutions. The duration of therapy and dosage of the drug Diazepam is determined by the doctor individually.
Adults with diseases that are accompanied by severe psychomotor agitation and convulsions, as well as for the relief of epileptic seizures, are mainly prescribed the introduction of 10 mg of diazepam (2 ml of Diazepam 0.5%) up to 3 times a day.
The highest recommended single dosage of diazepam is 30 mg, the highest daily dosage is 70 mg. With epileptic status, a single dosage of diazepam can be increased to 40 mg. If necessary, in patients with status epilepticus, injections are repeated every 3-4 hours, but not more than 4 times a day.
A sedative result develops within a few minutes after intravenous administration of diazepam and within 30-40 minutes after intramuscular administration.
The recommended duration of therapy is 3 to 10 days.
After stopping the acute symptoms of the disease, it is proposed to continue therapy with the oral form of diazepam.
Recommended dosage for children:
With febrile convulsions, children 1-6 years old are mainly prescribed the introduction of 2-5 mg of diazepam per day.
With febrile convulsions, children aged 6-14 years are mainly prescribed the introduction of 5-10 mg of diazepam per day.
Children are encouraged to inject diazepam solution intravenously slowly.
After prolonged therapy, the withdrawal of Diazepam should be carried out gradually.

Side effects

Diazepam is often well tolerated by patients. In some cases, when using Diazepam, patients are likely to develop drowsiness, dizziness, lethargy, myasthenia gravis, and skin allergic reactions.
With prolonged use of the drug Diazepam, the development of drug dependence is likely.
With intravenous administration of Diazepam, local inflammatory reactions may develop; in order to prevent this undesirable effect, it is proposed to change the injection site with each injection.

Contraindications

Diazepam is not prescribed to patients with a history of intolerance reactions to the components of the solution, as well as drugs of the benzodiazepine group.
Diazepam is not used in the treatment of patients with myasthenia gravis and glaucoma.
Diazepam should not be used in patients with occupational limitations.
Diazepam is not prescribed to patients with alcoholism (with the exception of cases of alcohol withdrawal and alcoholic delirium).
Diazepam solution in pediatric practice is used only for the treatment of children older than 1 year.
Caution should be exercised when prescribing diazepam to patients at increased risk of developing drug dependence.
Potentially unsafe activities should be avoided during diazepam therapy.

Pregnancy

Diazepam is not used during pregnancy. According to vital indications, Diazepam can be used during pregnancy under the supervision of a physician for a minimum period of time and in the minimum effective doses.
If it is necessary to regularly use the drug Diazepam during lactation, it is necessary to decide on the termination of breastfeeding of the child.

Interaction with other drugs

Do not mix Diazepam solution in the same syringe with other medicines.
Diazepam potentiates the effects of barbiturates, phenothiazines, monoamine oxidase inhibitors, and other psychotropic drugs.
Drugs that depress the central nervous system, including hypnotics, sedatives, analgesics, antipsychotics and anesthetics, as well as antidepressants, potentiate the inhibitory effect of diazepam on the central nervous system.

Overdose

When using excessive doses of Diazepam, patients are likely to develop drowsiness, dysarthria, myasthenia gravis, and paradoxical arousal. With a further increase in dosage, patients developed a decrease in reflexes, loss of consciousness and coma. A lethal outcome with an overdose of diazepam is unlikely, but the risk increases significantly when using excessive doses of diazepam in combination with ethyl alcohol and other substances that potentiate the effects of benzodiazepines.
With an overdose of Diazepam, the development of arterial hypotension, respiratory depression and paradoxical reactions, including sleep disturbances, hallucinations and arousal, is also likely.
In case of an overdose of Diazepam, supportive therapy and constant monitoring of the patient's condition are prescribed. If necessary, use stimulants of the central nervous system and cardiovascular agents.

Release form

Solution for parenteral use Diazepam 2 ml in ampoules, 10 ampoules placed in blister packs are placed in a cardboard box.

Storage conditions

Diazepam in the form of a solution for parenteral use should be stored in rooms that maintain a temperature regime of 8 to 25 degrees Celsius.
The shelf life of Diazepam is 2 years.

Synonyms

Sibazone injection 0.5%.

Compound

2 ml of Diazepam (1 ampoule) contains:
Diazepam - 10 mg;
Additional substances.

A tranquilizer of the benzodiazepine group, it has an anxiolytic, sedative, muscle relaxant and anticonvulsant effect, potentiating the effects of the GABAergic system by stimulating the central action of GABA, the main inhibitory mediator of the brain. Benzodiazepine derivatives act in the same way as benzodiazepine receptor agonists, which form a component of a functional supramolecular unit known as the benzodiazepine-GABA-chlorionophore receptor complex, located on the neuron membrane.
Due to the selective stimulating effect on GABA receptors in the ascending reticular formation of the brain stem, it reduces the excitation of the cortex, limbic region, thalamus and hypothalamus and has an anxiolytic and sedative-hypnotic effect. Due to the inhibitory effect on polysynaptic spinal reflexes, it has a muscle relaxant effect.
Diazepam is quickly and completely absorbed in the digestive tract; The maximum plasma concentration is reached 30-90 minutes after ingestion. After an intramuscular injection, it is also completely absorbed, although this process is not always faster than after oral administration. The elimination curve of diazepam has a biphasic character: an initial phase of rapid and extensive distribution with a half-life of up to 3 hours is followed by a long terminal phase of elimination (with a half-life of up to 48 hours). Diazepam is metabolized to the pharmacologically active nordiazepam (half-life 96 hours), hydroxydiazepam and oxazepam. Diazepam and its metabolites bind to plasma proteins (98% diazepam); excreted mainly in the urine (about 70%) in the form of free or conjugated metabolites.
The half-life may increase in newborns, elderly and senile patients and in patients with liver or kidney disease; at the same time, a longer time may be required to achieve an equilibrium concentration in the blood plasma. Diazepam and its metabolites pass through the BBB and the placental barrier. They are also found in breast milk at a concentration of approximately 1/10 of the concentration in maternal plasma.

Indications for the use of the drug Diazepam

Inside for the symptomatic treatment of patients in a state of anxiety (may be manifested by a pronounced anxious mood, behavior and / or its functional, vegetative or motor equivalents - palpitations, excessive sweating, insomnia, tremors, anxiety, etc.), agitation and tension in neurosis and transient reactive states; as an aid in severe mental and organic disorders.
Used parenterally to provide a sedative effect before stressful medical or diagnostic procedures such as electrical impulse therapy, cardiac catheterization, endoscopy, certain x-ray examinations, small volume surgeries, reduction of dislocations and reposition of bones in fractures, biopsy, burn wound dressing, etc .; to eliminate anxiety, fear, prevent acute stress; for premedication before surgery in patients experiencing a feeling of fear or tension; in psychiatry to eliminate the state of excitation associated with acute anxiety and panic, as well as motor agitation, paranoid-hallucinatory states, alcoholic delirium; for the emergency treatment of status epilepticus and other convulsive conditions (tetanus, eclampsia); in order to facilitate the course of the first stage of childbirth.
Both routes of administration are used to eliminate reflex muscle spasms in case of local damage (trauma, wound, inflammation); as an effective adjuvant for the relief of spastic conditions caused by damage to the spinal and supraspinal intermediate neurons (for example, with cerebral palsy and paraplegia, with athetosis and stiffness syndrome).

The use of the drug Diazepam

To achieve the optimal effect, the dose is selected individually. The usual oral dose for adults is 5-20 mg/day, depending on the severity of the symptoms. A single oral dose should not exceed 10 mg.
In urgent cases or in life-threatening conditions, as well as with insufficient effect from oral administration, parenteral administration of diazepam in higher doses is possible.
Treatment of anxiety conditions is usually carried out for several weeks, depending on the type of pathology and etiological factors. Positive clinical dynamics is observed within 6 weeks from the start of the use of diazepam; in the future, maintenance therapy is usually carried out. Systematic clinical studies of the effectiveness of long-term (more than 6 months) use of diazepam have not been conducted. In elderly and senile patients, oral treatment should begin with half the usual adult dose, gradually increasing it depending on need and tolerability.
Children are prescribed orally at a dose of 0.1-0.3 mg / kg / day.
In diseases of the kidneys or liver, the dose should be selected individually.
To achieve a sedative effect with the preservation of consciousness, before carrying out stressful procedures, adults are injected intravenously with 10-30 mg, children - 0.1-0.2 mg / kg of body weight. The initial dose is 5 mg (children - 0.1 mg / kg), then re-introduced every 30 seconds at a dose 50% higher than the initial one.
For premedication, adults are injected intramuscularly with 10-20 mg, children - 0.1-0.2 mg/kg 1 hour before induction of anesthesia; induction anesthesia - 0.2-0.5 mg / kg is injected intravenously.
In states of excitation (acute anxiety states, motor agitation, alcoholic delirium), the initial dose is 0.1-0.2 mg / kg IM or IV every 8 hours until the severity of acute symptoms decreases; maintenance therapy is carried out by oral administration.
In case of status epilepticus, it is administered intravenously in a stream every 10-15 minutes or in / in a drip of 0.15-0.25 mg / kg; the highest daily dose is 3 mg/kg.
With tetanus - 0.1-0.3 mg / kg IV every 1-4 hours. Diazepam can be administered intravenously by drip or through a gastric tube (3-4 mg / kg per day).
In the case of muscle spasm (with injuries, spinal and supraspinal paralysis), diazepam is used in the same doses as for achieving a sedative effect while maintaining consciousness.
With preeclampsia and eclampsia, 10-20 mg is administered intravenously; if necessary, prescribe an additional injection of intravenous jet or drip (the highest daily dose is 100 mg).
To facilitate labor activity - 10-20 mg intramuscularly (in the presence of pronounced excitation - intravenously) with the opening of the cervix by 2-3 fingers.

Contraindications to the use of the drug Diazepam

Hypersensitivity to benzodiazepines in history; alcohol dependence (with the exception of the treatment of acute withdrawal symptoms); severe form of chronic hypercapnia, severe liver failure.

Side effects of diazepam

Most often - lethargy, drowsiness and muscle weakness (usually depends on the dose); rarely - confusion, constipation, depression, dullness of emotions, decreased attention, diplopia, dysarthria, headache, arterial hypotension, urinary incontinence, increased or decreased sexual desire, nausea, xerostomia or increased salivation, skin rash, slurred speech, tremor, delay urine, headache, dizziness, blurred vision; very rarely - increased activity of transaminases and alkaline phosphatase, as well as jaundice.
Paradoxical reactions such as acute agitation, anxiety, sleep disturbances, and hallucinations have been described; when they appear, diazepam should be discontinued.
With parenteral use - thrombosis and thrombophlebitis, local irritation (especially after rapid intravenous administration). Diazepam solution should not be injected into very small veins; it is unacceptable to / and the introduction and ingress of the solution into the adjacent tissues. IM injections may be accompanied by soreness and erythema.

Special instructions for the use of the drug Diazepam

The use of benzodiazepine derivatives and similar drugs can lead to the formation of physical and mental dependence, the risk of which increases with high doses and prolonged treatment. It also increases in patients with a burdened history (abuse of alcohol and drugs). Individuals taking diazepam at recommended doses are less likely to develop physical dependence. Abrupt withdrawal of diazepam after prolonged use may cause withdrawal symptoms (headache and myalgia, severe anxiety, tension, restlessness, confusion and irritability). In severe cases, the following symptoms may occur: derealization, depersonalization, hyperacusis, numbness and tingling in the limbs, light, sound and tactile hypersensitivity, hallucinations and epileptic seizures. Therefore, the dose of diazepam is recommended to be reduced gradually.
When prescribing diazepam to patients with severe pseudoparalytic myasthenia gravis, their muscle weakness should be taken into account.
Use with caution in heart and respiratory failure, since sedatives can aggravate respiratory depression; however, sedation may be beneficial for some patients as it reduces respiratory effort.
As in the case of the use of other psychotropic drugs, the dose of diazepam should be selected taking into account individual tolerability in patients with organic changes in the brain (especially atherosclerosis) or with heart and respiratory failure. As a rule, diazepam should not be administered parenterally to such patients.
It is necessary to warn patients against drinking alcohol while taking diazepam, since this combination can potentiate the negative effect of each of them.
Before prescribing diazepam during pregnancy, it is necessary to compare the expected therapeutic effect for the mother and the potential harm to the fetus. It should be borne in mind that in newborns, the enzyme system involved in the metabolism of diazepam is underdeveloped (especially in preterm infants) and that diazepam and its metabolites pass through the placental barrier and penetrate into breast milk. Therefore, if possible, long-term use of diazepam during pregnancy and lactation should be avoided. The results of clinical observations indicate that the use of diazepam in obstetric practice is safe for the fetus.
Patients should refrain from driving and working with potentially dangerous mechanisms that require concentration and quick response.

Diazepam drug interactions

The simultaneous use of cimetidine (but not ranitidine) reduces the clearance of diazepam. There are also reports that diazepam interferes with the metabolism of phenytoin. There are no data on interaction with antidiabetic agents, anticoagulants and diuretics.
In the case of the combined use of diazepam and neuroleptics, tranquilizers, antidepressants, hypnotics, anticonvulsants, analgesics and anesthetics, mutual potentiation of effects is possible.
Diazepam in the form of a solution for injection should not be mixed in the same volume with other solutions, as this may lead to precipitation of the active substance.

Diazepam overdose, symptoms and treatment

It is manifested by a pronounced sedative effect, muscle weakness, deep sleep or paradoxical arousal. Intentional or accidental overdose of diazepam is rarely life-threatening. Significant overdose, especially when combined with other centrally acting agents, can cause coma, areflexia, cardiac and respiratory depression, and respiratory arrest.
Treatment - in most cases, only the control of vital signs is required. In case of severe overdose, appropriate measures are necessary (gastric lavage, mechanical ventilation, measures to maintain cardiovascular activity). The benzodiazepine antagonist flumazenil is recommended as a specific antidote.

List of pharmacies where you can buy Diazepam:

  • St. Petersburg

Diazepam
Tranquilizers (anxiolytics) of the benzodiazepine series

Release form

Solution d / in. 0.5%o (5 mg/ml), 2 ml
Tab. 2 mg, 5 mg, 10 mg

Mechanism of action

Stimulates benzodiazepine receptors, causes activation of GABA receptors and enhances GABAergic synaptic inhibition in the brain systems responsible for the regulation of emotional reactions, where GABA is a neurotransmitter (limbic system, thalamus, hypothalamus and reticular formation). It blocks the intercalary neurons of the spinal cord, providing a central muscle relaxant effect.

Main Effects

■ Anxiolytic.
■ Sedation.
■ Sleeping pills.
■ Anticonvulsant.
■ Muscle relaxant (central).
■ Vegetostabilizing.
■ Potentiates the action of drugs that depress the central nervous system.
■ May cause amnesia in high doses.

Pharmacokinetics

When taken orally, it is quickly and well (about 75% of the dose taken) absorbed from the gastrointestinal tract. With the / m introduction is absorbed completely, but more slowly than when taken orally. C^, in the blood depends on the dose and route of administration and is achieved when taken orally - 0.5-1.5 hours, with intramuscular injection - 0.5-2 hours. The volume of distribution in the equilibrium state is 0.8-1 l/kg. Undergoes biotransformation (98-99%) in the liver with the formation of active metabolites (N-desmethyldiazepam or nordiazepam, oxazepam and temazepam).

Plasma protein binding of diazepam and its active metabolites is 95-98%. T1 / 2 in adults is 20-70 hours (diazepam), 30-100 hours (nordiazepam), 9.2-2.4 hours (temazepam), 5-15 hours (oxazepam). T1 / 2 may be prolonged in newborns, elderly patients, with liver diseases. Diazepam and its active metabolites cross the BBB, the placental barrier and can be secreted in breast milk. It is excreted mainly by the kidneys in the form of metabolites (70%) and the intestines (10%). With repeated use, accumulation of diazepam and its metabolites in the blood plasma is observed.

Indications

■ Premedication before dental intervention to relieve psycho-emotional stress, fear, anxiety, agitation, increased irritability.
■ Insomnia, incl. the day before the operation.
■ In anesthesiology - as part of a balanced anesthesia and ataralgesia, for potentiated anesthesia.
■ Chronic diseases of the maxillofacial region, accompanied by neurotic disorders (as part of complex therapy).
■ Chronic diseases of the maxillofacial region, accompanied by pain syndrome (in complex therapy): stomalgia, glossalgia, neuralgia.
■ Bruxism, trismus and other diseases of the temporomandibular joint, accompanied by tension and spasm of the masticatory muscles.
■ Relief of status epilepticus and acute psychomotor agitation at a dental appointment.

Dosage and administration

Inside, in / in, in / m, rectally.

Inside: for premedication in adults at a dose of 5-10 mg 40-60 minutes before dental intervention. With course treatment, a single dose is 5-10 mg, a daily dose is 5-20 mg, on the eve of surgery in the evening - 10-20 mg.
The maximum single dose is 20 mg. The maximum daily dose is 60 mg.

With hypertonicity of masticatory muscles, 5 mg 2-3 times a day. Elderly and debilitated patients reduce the dose (usually 2.5 mg 1-2 times a day).

With intravenous and intramuscular administration, the average single dose for adults is 10-20 mg, the average daily dose is 30 mg, the maximum single dose is 30 mg, the maximum daily dose is 70 mg. The duration of treatment with injection of drugs should not exceed 3-5 days.

Children: at the age of 1-3 years - 1 mg 2 r / day, 3-7 years - 2 mg 3 r / day, over 7 years - 3-5 mg 2-3 r / day. The dose and duration of treatment in children are selected individually, depending on the indications, age and weight of the child.

Contraindications

■ Hypersensitivity.
■ Severe violations of the liver and kidneys.
■ Myasthenia gravis.
■ Glaucoma.
■ Ataxia.
■ Porfiria.
■ Severe heart and respiratory failure.
■ Alcohol abuse.
■ Suicidal tendencies.
■ Pregnancy.
■ Lactation.
■ Early childhood (up to 30 days).

Precautions, therapy control

With course treatment, drugs are canceled gradually. The duration of the course should not exceed 2 months due to the possibility of developing drug dependence.

Do not mix diazepam in the same syringe with other drugs.

During the period of treatment, one should refrain from driving vehicles, performing work that requires increased attention, speed of psychomotor reactions.

Benzodiazepines may reduce the analgesic effect of reflexology.

During the treatment period, the use of alcohol is unacceptable.

Prescribe with caution:
■ elderly and debilitated patients;
■ with heart, kidney and liver failure;
■ children under 6 months are used only for health reasons in a hospital.

Side effects

From the digestive system:
■ dry mouth;
■ nausea;
■ vomiting;
■ diarrhea or constipation;
■ loss of appetite;
■ weight loss;
■ increased activity of hepatic transaminases and alkaline phosphatase;
■ impaired liver function.

From the side of the central nervous system:
■ headache;
■ dizziness;
■ lethargy;
■ depression;
■ stunned;
■ muscle weakness;
■ increased fatigue;
■ tremor;
■ nystagmus;
■ blurred vision;
■ dysarthria, slurred speech;
■ diplopia;
■ dulling of emotions;
■ ataxia;
■ decrease in speed of reactions and concentration of attention;
■ drowsiness;
■ deterioration of short-term memory;
■ confusion;
■ fainting;
■ paradoxical reactions (excitement, anxiety, hallucinations, nightmares, fits of rage, inappropriate behavior);
■ anterograde amnesia.

From the genitourinary system:
■ incontinence or urinary retention;
■ decreased libido and potency;
■ violation of the menstrual cycle.

From the side of the cardiovascular system and the blood system:
■ bradycardia;
■ neutropenia.

Other effects:
■ drug dependence (with prolonged use);
■ allergic reactions. Local reactions:
■ phlebitis and thrombophlebitis at the injection site (with intravenous administration);
■ infiltrates at the injection site (for intramuscular injection).

Overdose

Symptoms: lethargy, muscle weakness, lethargy, amnesia and deep sleep, sometimes up to 2 days; rarely - dysarthria, rigidity or clonic twitching of the limbs, in very high doses - respiratory and cardiac depression, apnea, areflexia, coma.

Treatment: drug withdrawal, gastric lavage (when diazepam is used orally), intravenous administration of a specific antagonist of benzodiazepine tranquilizers - flumazenil (aneksat), symptomatic supportive therapy.

Interaction

Synonyms

Valium rosh (Switzerland), Relanium (Poland), Seduxen (Russia, Hungary), Sibazon (Russia)

G.M. Barer, E.V. Zoryan

Diazepam indications. From the side of the cardiovascular system


Presented are analogues of the drug diazepam, in accordance with medical terminology, called "synonyms" - drugs that are interchangeable in terms of effects on the body, containing one or more identical active substances. When choosing synonyms, consider not only their cost, but also the country of origin and the reputation of the manufacturer.

Description of the drug

Diazepam- A tranquilizer, a benzodiazepine derivative. It has an anxiolytic, sedative, anticonvulsant, central muscle relaxant effect. The mechanism of action is associated with an increase in the inhibitory effect of GABA in the central nervous system. The muscle relaxant effect is also due to the inhibition of spinal reflexes. May cause anticholinergic effects.

List of analogues

Note! The list contains synonyms for Diazepam, which have a similar composition, so you can choose a replacement yourself, taking into account the form and dose of the medicine prescribed by your doctor. Give preference to manufacturers from the USA, Japan, Western Europe, as well as well-known companies from Eastern Europe: Krka, Gedeon Richter, Actavis, Egis, Lek, Geksal, Teva, Zentiva.


Release form(by popularity)price, rub.

Reviews

Below are the results of surveys of visitors to the site about the drug diazepam. They reflect the personal feelings of the respondents and cannot be used as an official recommendation for treatment with this drug. We strongly recommend that you consult a qualified medical specialist for a personalized course of treatment.

Visitor survey results

Four visitors reported effectiveness


Your answer about side effects »

Two visitors reported a cost estimate

Members%
Expensive2 100.0%

Your answer about the cost estimate »

Five visitors reported frequency of intake per day

How often should I take diazepam?
Most of the respondents most often take this drug once a day. The report shows how often the other participants in the survey take this drug.
Your answer about dosage »

Six visitors reported a start date

How long does it take to take Diazepam to feel an improvement in the patient's condition?
Survey participants in most cases after > 3 months\. felt an improvement. But this may not correspond to the period after which you will improve. Talk to your doctor about how long you need to take this medicine. The table below shows the results of the survey on the beginning of an effective action.
Your answer about the start date »

Two visitors reported appointment time

When is the best time to take diazepam: on an empty stomach, before or after food?
Site users most often report taking this medicine on an empty stomach. However, your doctor may recommend a different time for you. The report shows when the rest of the interviewed patients take their medicine.
Your answer about the appointment time »

65 visitors reported patient age


Your answer about the age of the patient »

Visitor reviews


There are no reviews

Official instructions for use

There are contraindications! Before use, read the instructions

Diazepam

Diazepam
Trade name of the drug: Diazepam
International non-proprietary name: Diazepam
Chemical Name: 7-chloro-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one
Dosage form: Tablets
Compound
Tablets: Each tablet contains: 2 mg, 5 mg or 10 mg of diazepam, and excipients: microcrystalline cellulose, lactose monohydrate, corn starch, talc, silicon dioxide, magnesium stearate.
Description
Tablets 2mg: Round biconvex tablets of light orange color.
Tablets 5mg: Round biconvex tablets of light green color.
Tablets 10mg: Round biconvex white tablets.
Pharmacotherapeutic group Anxiolytic agent.

Pharmacological properties

Anxiolytic agent (tranquilizer) of the benzodiazepine series. It has a sedative, hypnotic, anticonvulsant and central muscle relaxant effect. It enhances the inhibitory effect of GABA in the central nervous system by increasing the sensitivity of GABA receptors to the mediator as a result of stimulation of benzodiazepine receptors, reduces the excitability of the subcortical structures of the brain, and inhibits polysynaptic spinal reflexes. The anxiolytic effect is manifested in the reduction of emotional stress, the weakening of anxiety, fear, anxiety; sedative effect - in relation to symptoms of neurotic origin: anxiety, fear. It practically does not affect the productive symptoms of psychotic genesis (acute delusional, hallucinatory, affective disorders), rarely there is a decrease in affective tension, delusional disorders.

Pharmacokinetics

Absorption is high. When taken orally, about 75% of the drug is absorbed; the time of onset of the maximum concentration in the blood plasma is 60-90 minutes; Steady-state concentration is achieved with constant intake after 1-2 weeks. Communication with plasma proteins - 98%. Metabolized in the liver 98-99% into pharmacologically active derivatives - nordiazepam, hydroxydiazepam and oxazepam. Diazepam and its metabolites cross the BBB and placental barriers and are found in breast milk at concentrations corresponding to 1/10 of plasma concentrations. In the form of glucuronides, metabolites are excreted in the urine (about 70%). 1-2% is excreted unchanged in the urine. Excretion has a two-phase character: the initial phase of rapid and extensive distribution (T 1/2 - Zch) is followed by a long phase (T Y* - 48 hours). T1 / 2 may be prolonged in newborns, elderly and senile patients, and in patients with hepatic and renal insufficiency.

Indications for use

Withdrawal alcohol syndrome: anxiety, nervous tension, anxiety (and / or autonomic equivalents of these disorders); neuroses, transient reactive states; psychosis and organic diseases of the central nervous system (as part of combination therapy as an additional agent); insomnia; spasm of skeletal muscles with local trauma; spastic conditions associated with damage to the brain or spinal cord (cerebral palsy, athetosis, tetanus); myositis, bursitis, arthritis, rheumatic pelvispondylitis, progressive chronic polyarthritis; arthrosis, accompanied by tension of skeletal muscles; vertebral syndrome, angina pectoris, arterial hypertension (as part of complex therapy); psychosomatic disorders in obstetrics and gynecology: climacteric and menstrual disorders, toxicosis of pregnant women; eczema, etc., diseases accompanied by itching, irritability.

Dosage and administration

Set individually, depending on the patient's condition, the clinical picture of the disease, sensitivity to the drug, age. Tablets are prescribed for children from 1 year. Elderly and senile patients should begin treatment with half the usual adult dose, gradually increasing it depending on the effect achieved and tolerability.
Psychiatry: with neurosis, hysterical or hypochondriacal reactions, dysphoria of various origins, phobias, alcohol withdrawal syndrome - 5-10 mg 2-3 times a day. If necessary, the dose can be increased to 60 mg / day. Elderly, debilitated patients, as well as patients with general atherosclerosis at the beginning of treatment - inside, 2 mg 2 times a day, if necessary, increase until the optimal effect is obtained. Working patients are recommended to take 2.5 mg 1-2 times a day or 5 mg (basic dose) in the evening. Neurology: spastic conditions of central origin in degenerative neurological diseases - inside, 5-10 mg 2-3 times a day, vertebral syndrome - 10 mg 4 times a day; as an additional remedy in physiotherapy of rheumatic pelvis spondylitis, progressive chronic polyarthritis, arthrosis - 5 mg 1-4 times a day. As part of the complex therapy of myocardial infarction: inside, 5-10 mg 1-3 times a day; in spastic conditions of rheumatic origin, vertebral syndrome - inside, 5 mg 1-4 times a day. Obstetrics and gynecology: psychosomatic disorders, menopausal and menstrual disorders, toxicosis of pregnant women - 2-5 mg 2-3 times a day. Preeclampsia - 5-10 mg orally 3 times a day.
Pediatrics: psychosomatic and reactive disorders, spastic states of central origin - are prescribed with a gradual increase in dose (starting with low doses and slowly increasing them to the optimal dose well tolerated by patients), the daily dose can be divided into 2-3 doses, with the main, most large dose - taken in the evening. Children 1-6 years old - 1-6 mg, 6-14 years old - 6-10 mg.

Side effects

Lethargy, drowsiness, muscle weakness; dulling of emotions, decreased attention, ataxia; confusion, depression, visual disturbances, diplopia, dysarthria, headache, tremor, dizziness; acute psychomotor agitation, anxiety, sleep disturbance, hallucinations (paradoxical reactions), constipation, nausea, dry mouth, hypersalivation; increased activity of "liver" transaminases and alkaline phosphatase, jaundice, drug dependence; increase or decrease in libido, urinary incontinence, skin rash.

Contraindications

Individual intolerance to the drug, myasthenia gravis; suicidal tendencies; alcohol dependence (in history, except for acute withdrawal), drug dependence; hypercapnia; lactation period, acute attack of glaucoma, cerebral and spinal ataxia, hepatitis, sleep apnea, pregnancy (I and III trimester).

special instructions

The drug must be canceled with the development of peredoxical reactions (acute psychomotor agitation, anxiety, sleep disturbance, hallucinations). You should avoid the use of ethanol, refrain from engaging in activities that require increased attention and quick physical and mental reactions. The risk of developing drug dependence increases with the use of large doses, a significant duration of treatment, in patients who have previously abused ethanol or drugs. In the case of dependence, abrupt withdrawal of the drug is accompanied by a withdrawal syndrome (headache and muscle pain, anxiety, tension, restlessness, confusion, irritability; in severe cases, derealization, depersonalization, hyperacusis, paresthesia in the extremities, light and tactile hypersensitivity; hallucinations and epileptic seizures ).
Interaction with other drugs.
Enhances the inhibitory effect on the central nervous system of sedatives and antipsychotics, anxiolytics, antidepressants, central analgesics, anesthetics, muscle relaxants. Inhibitors of microsomal oxidation lengthen T1 / 2 and enhance the effect.

Overdose

Paradoxical excitation of the central nervous system; coma, areflexia, depression of cardiac and respiratory activity, apnea. First aid is to wash the stomach, taking activated charcoal. If necessary, symptomatic therapy in a hospital setting. The benzodiazepine antagonist flumazenil is used as a specific antidote. Hemodialysis is ineffective.

Release form

Tablets: 10 tablets in a blister, 3 blisters with instructions in a cardboard box.

Storage conditions

Store at a temperature of 15-25 C in a place protected from light and moisture, out of the reach of children.

Best before date

5 years.

Holiday conditions

By prescription.
Manufactured:
"Hemofarm concern" A.D., Yugoslavia
26300 Vrsac, Beogradsky way bb, Yugoslavia
phone: 13/821345, fax: 13/821424

The information on the page was verified by the therapist Vasilyeva E.I.

Name

diazepam tablets

Release form

tablets 5mg

INN

Diazepam
Analogues

Sibazon, Relium, Relanium, Diazepex

ATX code: N05BA01.
Compound

Each tablet contains:

active substance:

diazepam - 5 mg.
Pharmacotherapeutic group

Anxiolytics (tranquilizers). Benzodiazepines.
pharmachologic effect

It has a sedative-hypnotic, anticonvulsant and central muscle relaxant effect. Anxiolytic is manifested in a decrease in emotional stress, weakening anxiety, fear, anxiety. The sedative effect is manifested by a decrease in the symptoms of neurotic origin (anxiety, fear). Direct inhibition of motor nerves and muscle function is also possible. Possessing moderate sympatholytic activity, it can cause a decrease in blood pressure and dilation of the coronary vessels. Increases pain threshold. Reduces nocturnal secretion of gastric juice. The effect of the drug is manifested by 2-7 days of treatment. It practically does not affect the productive symptoms of psychotic genesis (acute delusional, hallucinatory, affective disorders), rarely there is a decrease in affective tension, delusional disorders. With withdrawal symptoms in chronic alcoholism, it causes a weakening of agitation, tremor, negativism, as well as alcoholic delirium and hallucinations. The therapeutic effect in patients with cardialgia, arrhythmias and paresthesia is observed by the end of 1 week of treatment.

Indications for use

  • anxiety disorders.
  • Dysphoria (as part of combination therapy as an additional drug).
  • Insomnia (difficulty falling asleep).
  • Spasm of skeletal muscles with local trauma;
  • spastic conditions associated with damage to the brain or spinal cord (cerebral palsy, athetosis, tetanus);
  • myositis,
  • bursitis,
  • arthritis,
  • rheumatic pelvis spondylitis,
  • progressive chronic polyarthritis;
  • arthrosis,
  • accompanied by tension of skeletal muscles;
  • vertebral syndrome,
  • angina,
  • tension headache.
  • Withdrawal alcohol syndrome (anxiety, tension, agitation, tremor, transient reactive states).

As part of complex therapy:

  • arterial hypertension,
  • peptic ulcer of the stomach and duodenum;
  • psychosomatic disorders in obstetrics and gynecology:
  • climacteric and menstrual disorders,
  • preeclampsia;
  • epileptic status;
  • eczema and other diseases accompanied by itching, irritability.
  • Meniere's disease.
  • Drug poisoning.
  • Premedication before surgical interventions and endoscopic manipulations, general anesthesia th.

Dosage and administration

The drug is taken orally. The dose is calculated individually depending on the patient's condition, clinical picture of the disease, sensitivity to the drug.

As an anxiolytic drug, it is prescribed orally, 2.5-10 mg 2-4 times a day.

Psychiatry: with neurosis, hysterical or hypochondriacal reactions, dysphoria of various origins, phobias - 5-10 mg 2-3 times a day. If necessary, the dose can be increased to 60 mg / day.

With alcohol withdrawal syndrome - 10 mg 3-4 times a day for the first 24 hours, followed by a decrease to 5 mg 3-4 times a day.

Elderly, debilitated patients, as well as patients with atherosclerosis at the beginning of treatment - orally, 2 mg 2 times a day, if necessary, increase until the optimal effect is obtained. Working patients are recommended to take 2.5 mg 1-2 times a day or 5 mg (basic dose) in the evening.

Neurology: spastic conditions of central origin in degenerative neurological diseases - orally, 5-10 mg 2-3 times a day.

Cardiology and rheumatology: angina - 2-5 mg 2-3 times a day; arterial hypertension - 2-5 mg 2-3 times a day, vertebral syndrome in bed rest - 10 mg 4 times a day; as an additional drug in physiotherapy for rheumatic pelvis spondyloarthritis, progressive chronic polyarthritis, arthrosis - 5 mg 1-4 times a day.

As part of the complex therapy of myocardial infarction: inside, 5-10 mg 1-3 times a day; vertebral syndrome - inside, 5 mg 1-4 times a day.

Obstetrics and gynecology: psychosomatic disorders, menopausal and menstrual disorders, gestosis - 2-5 mg 2-3 times a day. Preeclampsia - orally 5-10 mg orally 3 times a day.

Anesthesiology, surgery: premedication - on the eve of surgery, in the evening - 10-20 mg orally. Pediatrics: psychosomatic and reactive disorders, spastic states of central origin - are prescribed with a gradual increase in dose (starting with low doses and slowly increasing them to the optimal dose well tolerated by the patient), daily dose (can be divided into 2-3 doses, with the main dose the largest dose is taken in the evening): children from 6 months and older - 1-2.5 mg (or 40-200 mcg / kg, or 1.17-6 mg / sq.m) 3-4 times a day; from 1 year to 3 years - 1 mg; from 3 to 7 years - 2 mg; from 7 years and older - 3-5 mg. Daily doses - 2, 6 and 8-10 mg, respectively.
special instructions

In the process of treatment, patients are strictly prohibited from using ethanol. In case of renal / hepatic insufficiency and long-term treatment, it is necessary to control the pattern of peripheral blood and "liver" enzymes. The risk of developing drug dependence increases with the use of large doses, a significant duration of treatment, in patients who have previously abused ethanol or drugs. Without special instructions should not be used for a long time. It is unacceptable to abruptly stop treatment due to the risk of "withdrawal" syndrome (headache, myalgia, anxiety, tension, confusion, irritability; in severe cases, derealization, depersonalization, hyperacusis, photophobia, tactile hypersensitivity, paresthesias in the extremities, hallucinations and epileptic seizures), however, due to the slow half-life of diazepam, its manifestation is much weaker than that of other benzodiazepines. If patients experience such unusual reactions as increased aggressiveness, acute states of arousal, anxiety, fear, suicidal thoughts, hallucinations, increased muscle cramps, difficulty falling asleep, superficial sleep, treatment should be discontinued.

Side effects

From the nervous system: at the beginning of treatment (especially in elderly patients) - drowsiness, dizziness, increased fatigue, decreased ability to concentrate, ataxia, disorientation, gait instability and poor coordination of movements, lethargy, dullness of emotions, slowing down of mental and motor reactions, anterograde amnesia (more than often than when taking other benzodiazepines); rarely - headache, euphoria, depression, tremor, depressed mood, catalepsy, confusion, dystonic extrapyramidal reactions (uncontrolled body movements, including the eyes), weakness, myasthenia gravis during the day, hyporeflexia, dysarthria; extremely rarely - paradoxical reactions (aggressive outbursts, psychomotor agitation, fear, suicidal tendencies, muscle spasm, confusion, hallucinations, acute agitation, irritability, anxiety, insomnia).

From the side of the hematopoietic organs: leukopenia, neutropenia, agranulocytosis (chills, pyrexia, sore throat, excessive fatigue or weakness), anemia, thrombocytopenia.

From the digestive system: dry mouth or hypersalivation, heartburn, hiccups, gastralgia, nausea, vomiting, loss of appetite, constipation; abnormal liver function, increased activity of "liver" transaminases and alkaline phosphatase, jaundice.

From the side of the cardiovascular system: palpitations, tachycardia, lowering blood pressure (with parenteral administration).

From the genitourinary system: Urinary incontinence, urinary retention, impaired renal function, increased or decreased libido, dysmenorrhea.

Allergic reactions: skin rash, itching.

Effect on the fetus: teratogenicity (especially the first trimester), CNS depression, respiratory failure and suppression of the sucking reflex in newborns whose mothers used the drug.

Local reactions: at the injection site - phlebitis or venous thrombosis (redness, swelling or pain at the injection site).

Others: addiction, drug dependence; rarely - depression of the respiratory center, impaired function of external respiration, impaired vision (diplopia), bulimia, weight loss. With a sharp decrease in the dose or discontinuation of the intake, the “withdrawal” syndrome (irritability, headache, anxiety, excitement, agitation, fear, nervousness, sleep disturbances, dysphoria, spasm of the smooth muscles of the internal organs and skeletal muscles, depersonalization, increased sweating, depression, nausea, vomiting, tremor, perception disorders, including hyperacusis, paresthesia, photophobia, tachycardia, convulsions, hallucinations, rarely acute psychosis). When used in obstetrics - in full-term and premature babies - muscle hypotension, hypothermia, dyspnea.

Contraindications

Hypersensitivity, coma, shock, acute alcohol intoxication with weakening of vital functions, acute intoxication with drugs that have a depressant effect on the central nervous system (including narcotic analgesics and hypnotics), myasthenia gravis, angle-closure glaucoma (acute attack or predisposition); severe COPD (danger of progression of the degree of respiratory failure), acute respiratory failure, pregnancy (especially the first trimester), lactation, children under 6 months of age.

Precautions: history of epilepsy or epileptic seizures (initiation of treatment with diazepam or its abrupt withdrawal may accelerate the development of seizures or status epilepticus), absence or Lennox-Gastaut syndrome (when administered intravenously contributes to tonic status epilepticus), hepatic and / or renal insufficiency, cerebral and spinal ataxias, hyperkinesis, history of drug dependence, addiction to psychoactive drugs, organic brain diseases, hypoproteinemia, sleep apnea (established or suspected), old age.
Precautionary measures

Initiation of diazepam treatment or its abrupt withdrawal in patients with epilepsy or with a history of epileptic seizures may accelerate the development of seizures or status epilepticus. During pregnancy, they are used only in exceptional cases and only for "vital" indications. It has a toxic effect on the fetus and increases the risk of congenital malformations when used in the first trimester of pregnancy. Taking therapeutic doses later in pregnancy may cause CNS depression in the newborn. Continuous use during pregnancy can lead to physical dependence - possible "withdrawal" syndrome in the newborn. Children, especially at a younger age, are very sensitive to the CNS depressant effects of benzodiazepines. Newborns are not recommended to prescribe drugs containing benzyl alcohol - a fatal toxic syndrome may develop, manifested by metabolic acidosis, CNS depression, difficulty breathing, renal failure, decreased blood pressure and, possibly, epileptic seizures, as well as intracranial hemorrhages.

During the period of treatment, care must be taken when driving vehicles and engaging in other potentially hazardous activities that require an increased concentration of attention and speed of psychomotor reactions.
Interaction with other drugs

Enhances the inhibitory effect on the central nervous system of ethanol, sedative and antipsychotic drugs (neuroleptics), antidepressants, narcotic analgesics, drugs for general anesthesia, muscle relaxants. Microsomal oxidation inhibitors (including cimetidine, oral contraceptives, erythromycin, disulfiram, fluoxetine, isoniazid, ketoconazole, metoprolol, propranolol, propoxyphene, valproic acid) prolong the half-life of diazepam and increase the effect. Inducers of microsomal liver enzymes reduce the effectiveness. Narcotic analgesics increase euphoria, leading to an increase in psychological dependence. Antihypertensive drugs may increase the severity of lowering blood pressure. Against the background of the simultaneous appointment of clozapine, it is possible to increase respiratory depression. With simultaneous use with low-polarity cardiac glycosides, an increase in the concentration of the latter in the blood serum and the development of digitalis intoxication (as a result of competition for binding to plasma proteins) are possible. Reduces the effectiveness of levodopa in patients with parkinsonism. Omeprazole prolongs the elimination time of diazepam. MAO inhibitors, analeptics, psychostimulants - reduce activity. Premedication with diazepam reduces the dose of fentanyl required for induction of general anesthesia and reduces the time required to "turn off" consciousness with induction doses.

May increase zidovudine toxicity. Rifampicin may increase the excretion of diazepam and decrease its plasma concentrations. Theophylline (used in low doses) can reduce or even reverse the sedative effect.
Overdose

Symptoms:

drowsiness, confusion, paradoxical agitation, decreased reflexes, areflexia, stupor, reduced response to pain stimuli, deep sleep, dysarthria, ataxia, visual disturbance (nystagmus), tremor, bradycardia, shortness of breath or shortness of breath, apnea, severe weakness, decreased blood pressure , collapse, depression of cardiac and respiratory activity, coma.

Treatment:

taking a large amount of liquid, gastric lavage, taking activated charcoal and immediately contacting a doctor.
Release form

Tablets of 5 mg in pack No. 20 (No. 10x2 in blister packs).

Manufacturer

RUE "Belmedpreparaty"

CATEGORIES

POPULAR ARTICLES

2022 "kingad.ru" - ultrasound examination of human organs